peptides. [8] [9] [10] An infection model using TLR4-deficient, bone marrow chimeric mice with reconstituted wild-type or TLR4
-/-bone marrow (i.e. TLR4-deficient stromal cells were combined with wild-type or receptor-deficient myeloid cells) has demonstrated a significant role of stromal TLR expression for the initiation of cellular leukocyte infiltration and microbial clearance in the urinary bladder. 11 Similarly, chimeric mice that lacked stromal TLR4 expression revealed significant impairment of leukocyte recruitment in a pulmonary LPS exposure model. 12 Thus, endothelial and epithelial cells at primarily sterile body sites produce chemokines in response to microbial challenge to attract professional immune cells. PRRs might thereby work as sentinels to detect micro-organisms that gain access to sterile body surfaces as seen in the upper urogenital tract or the lower respiratory tract.
Only recently, activation of cytosolic NOD2 by type IV effector protein translocation of Helicobacter pylori has been reported to lead to epithelial cell activation. 13 In addition, electron microscopy studies using intestinal tissue sections have demonstrated TLR9-dependent degranulation of intestinal Paneth cells indicating TLRmediated antimicrobial peptide secretion, an important effector mechanism of intestinal host defense.
14 Paneth cells were also reported to express NOD2 which might indicate a more complex regulatory network. 15 Finally, TLR-mediated recognition of the commensal microflora within the intestinal tract was recently reported to promote epithelial proliferation and tissue repair following chemical colitis. 16 Together, these data indicate a functional role of epithelial PRR expression in the initial host defense and the recruitment of professional immune cells.
Inhibition of epithelial TLR signalling in the presence of a microbial flora
The presence of functionally active TLR receptors that recognize microbial structures by epithelial cells raises an important unresolved question. In contrast to the situation at sterile internal body sites, many epithelial surfaces are densely populated by, or at least transiently exposed to, a highly diverse and dynamic microbial flora. 17 This is mainly the case along the gastrointestinal tract, but also on the skin and within the upper respiratory and the lower urogenital tract. In addition, the ubiquitous presence of microbes in the environment leads to significant contamination of body surfaces with microbial compounds such as LPS even in the absence of living microbial organisms. Thus, the recognition of microbial structures by epithelial cells at diverse anatomical sites generally does not indicate 'infectious non-self', but rather represents the physiological situation in a microbially inhabited environment. This, in turn, necessitates negative regulatory mechanisms in vivo to avoid unintended stimulation on colonized anatomical surfaces. Initial work proposed down-regulation of TLR receptors following stimulation to mediate tolerance, although this effect is unlikely to cause the functional block seen in tolerant cells. 18 Subsequently, an array of negative regulators of TLR signalling has been described and some have also been shown to be active in epithelial cells. Possible mechanisms include the expression of inhibitory TLR-like molecules such as T1/ST2 or SIGIRR that competitively inhibit signal transduction. [19] [20] [21] Also, expression of an alternatively spliced, short form of MyD88 (sMyD88), or up-regulation of Tollip, a negative regulator of Mal/TIRAP, have been proposed. 22, 23 There is evidence that enhanced expression of Tollip might contribute to the LPS nonresponsive phenotype of previously exposed intestinal cells. 24 Furthermore, various differentially spliced forms of interleukin 1-receptor associated kinase (IRAK)2 (such as IRAC2c and IRAC2d) or expression of the inhibitory IRAK-M have been associated with signal inhibition. 25, 26 Other potential factors that might exert negative effects on TLR signalling are SH 2 -containing inositol phosphatase (SHIP) or A20. 27, 28 Commensal bacteria might specifically trigger antiinflammatory pathways as shown for B. thetaiotaomicron which causes a peroxisome proliferator-activated receptor (PPAR)-γ-dependent nuclear export of the NF-κB subunit RelA in colonic epithelial cells. 29 NOD2, a cytosolic inducible PRR also expressed in epithelial cells, was recently proposed to mediate negative regulation of TLR2. 30 Failure of this negative feedback loop due to a loss of function mutation in the NOD2 gene might explain the pathophysiology of a subgroup of patients with inflammatory bowel disease. 31, 32 Similar to macrophages, epithelial cells acquire resistance to repeated TLR ligand stimulation, a phenomenon first discovered for LPS and termed tolerance. 5 Interestingly, primary stimulation through one TLR receptor also negatively affects subsequent signalling by other members of this receptor family (and the interleukin 1 [IL-1] receptor) indicating inhibition of a common signalling pathway. 33 Thus, tolerance might be the phenotypical correlate of negative TLR regulation and help to maintain the integrity of microbially colonized body surfaces. Conversely, the inhibition of TLR activation could also abolish the beneficial role of TLRs in sensing infection with pathogenic bacteria.
Structural differences between PRR ligands of commensal and pathogenic micro-organisms
There is recent experimental evidence that epithelial cells might discriminate between benign colonization and the presence of pathogens. Structural differences within the recognized ligands between commensal or pathogenic bacteria might allow for this discrimination. Lipopolysaccharide (LPS) isolated from Bacteroides fragilis, a typical commensal gut bacterium, was found to be 100-1000 less potent in the stimulation of TLR4-mediated cytokine induction. 34 Hypo-acylated LPS produced by many members of the gut microflora competitively inhibits recognition by wild-type hexa-acylated LPS indicating a possible role of the intestinal flora to maintain the intestinal integrity. 35 However, other typical commensal bacteria such as Escherichia coli produce hexa-acylated LPS and the physiological importance of this competitive antagonism (i.e. the concentrations of the different LPS species at a given anatomical site in vivo) is unknown. In addition, mouse TLR4 readily recognizes penta-acylated LPS arguing against a general inhibitory mechanism exerted by competitive antagonists produced by the commensal microflora. Also, some pathogenic microbes are able to modify their recognized structures to a certain extent in order to reduce the stimulatory potential and evade efficient immune defense activation. Examples are virulence co-regulated LPS modifications of the enteric pathogens Salmonella or Yersinia (such as addition of aminoarabinose or hypo-acylation), or the non-stimulatory flagellin produced by H. pylori, the causative agent of gastric ulcer disease. [36] [37] [38] A possible example for a pathogenicity-associated microbial structure has been reported for certain types of E. coli. TLR11 mainly expressed in the murine kidney was recently shown to mediate protection from upper urogenital infection with uropathogenic E. coli. 39 The ligand(s) of TLR11 have not yet been identified, but their expression appears to be restricted to uropathogenic E. coli since non-pathogenic E. coli strains failed to cause TLR11-dependent cell activation. Possible candidates are the P-fimbriae, which are required for uropathogenicity 40 . Many undoubtedly 'pathogenic' micro-organisms colonize healthy individuals for prolonged periods of time. Examples are Streptococcus pneumoniae, Haemophilus influenzae or Neisseria meningitidis. All three microorganisms are able to cause severe and even life-threatening respiratory tract and central nervous system infections, but are also found as colonizers in a significant number of healthy individuals without any visible signs of inflammation or clinical infection. Thus, under these resting conditions, immune recognition might not, and cellular activation does not, take place. It is tempting to speculate that the recognition of these pathogens relies on microbial structures such as the polysaccharide capsule that is predominantly expressed during invasive infections. 41, 42 Capsular polysaccharides protect the bacteria against phagocytosis, and thereby contribute to their invasiveness and immune evasion. However, polysaccharide capsules themselves have not yet been shown to mediate cellular activation, but rather prevent initial immune stimulation via shielding PRR ligands of the bacterial cell wall. Together, it currently appears unlikely that structural differences within PRR ligands generally allow for the discrimination between benign commensal and pathogenic micro-organisms. All bacterial TLR ligands identified so far (such as LPS, di-or tri-acylated lipopeptides, CpG DNA, or flagellin) are highly conserved and shared by both commensal and pathogenic bacterial species. In this respect, the designation of TLR ligands as pathogen-associated microbial patterns (PAMPs) is certainly not appropriate. Described variations within TLR ligands might rather indicate a general evolutionary pressure on pathogenic as well as commensal micro-organisms to avoid recognition and immune activation to preserve their respective ecological niches.
Pathogen recognition by PRR expression on cells at non-colonized anatomical sites
Epithelial cells might recognize pathogenic microorganisms via their capability to access or survive in defined anatomical localizations. For example, the intestinal crypts have been proposed to represent such a restricted anatomical site. Crypt epithelial cells have been reported to express TLR4 selectively. 43 Paneth cells at the bottom of the intestinal crypts produce large amounts of antimicrobial peptides that block the stimulatory activity of LPS and rapidly eliminate approaching bacteria. Intestinal crypts might, therefore, represent sentinel guards against commensal as well as pathogenic bacteria. Salmonella, a prominent enteropathogenic bacterium has been reported to exhibit diminished susceptibility towards antimicrobial peptide mediated killing. It might, therefore, be able to reach and survive within the upper parts of the crypt lumen. 44 A problem with this hypothesis is the continuous renewal of intestinal epithelial cells that originate from stem cells situated at the base of the crypts and grow up to the villus tip where they are finally shedded into the intestinal lumen. This epithelial cell differentiation only takes a few days and it seems unlikely that the restricted expression of TLR4 by crypt cells would secure the absence of TLR4 protein within villus cells that are exposed to the luminal commensal bacteria.
Another example of such an anatomically restricted PRR expression might be the described localization of TLR5, the receptor for flagellin. Expression of TLR5 was reported to be limited to the basolateral membrane of polarized epithelial cells. 45 Recognition would, therefore, indicate bacterial penetration or leakage of the epithelial barrier and justify host defense activation. However, there has been some debate on the complete absence of TLR5 on the apical cell surface and whether this restricted expression is also found in vivo. 46 
Intracellular restriction of PRR expression to recognize microbial pathogenicity
Finally, the discrimination between commensal and pathogenic bacteria might result from the ability of pathogenic micro-organisms to invade and survive within eukaryotic cells. In fact, the invasive phenotype of pathogenic bacteria has previously been linked to enhanced cellular activation. 47 Enteropathogenic Salmonella, Shigella, and Listeria gain access to different intracellular compartments. Recognition of Shigella and Listeria that exit the endosomal vacuole and persist within the cytosol might occur via NOD proteins. 48 NOD proteins also allow the detection of peptidoglycan fragments translocated together with virulence factors into the eukaryotic cytosol via specific bacterial secretion systems as seen in H. pylori infection. 13 In contrast, Salmonella remains in tight phagosomes, so-called Salmonella containing vacuoles (SCV), where it is also able to replicate. Interestingly, TLR4 expression in a murine intestinal epithelial cell line has been demonstrated to be largely restricted to the Golgi apparatus, a cellular organelle with abundant exchange with other cellular endosomal compartments. 5 The intravesicular localization of TLR4 might thereby facilitate recognition of invasive, intracellular pathogens that remain within endosomal compartments. Thus, TLR4 and NOD proteins seem to monitor the cytosol or the endosomes of epithelial cells for the presence of pathogens. In professional immune cells, the intracellular endosomal localization of the receptors of single stranded RNA (ssRNA) and CpG DNA, TLR7 and TLR9 has been invoked as a protective measure to avoid stimulation by endogenous ligands. 49, 50 Similarly, the intracellular localization of NODs and TLR4 might enable epithelial 'cells' to differentiate extracellular commensal bacteria from invasive enteric pathogens. 51 
Concluding remarks
We are left with many questions, indicating the illdefined role of epithelial cells during the activation of the host defense. Careful in vivo studies on the function, signalling, and modulation of epithelial TLR-mediated signalling and their role in the host-microbe homeostasis are needed. It is clear that epithelial cells express PRRs and can mediate leukocyte recruitment and secrete specific host defense effector molecules. This certainly contributes to the maintenance of sterile body surfaces within the lower respiratory and the upper urogenital tract. The role of PRRs on colonized surfaces such as the intestinal tract, however, is unclear and the mechanisms that facilitate differentiation between harmless commensal bacteria and pathogenic microbes remain to be further defined. To tackle this formidable task will certainly add significantly to our understanding of the complex host-microbe relationship.
